In addition, TRAIL exerts its anti-inflammatory effects directly through inhibiting T cell activation via TRAIL-R signaling, suggesting an apoptosis-independent pathway in suppressing inflammatory arthritis by TRAIL, and a novel role for TRAIL in regulating CD4+ T cell activation and modulating autoimmune diseases. Here, TNFSF10 is linked to autoimmune disease.